Lack of BACE1 S-palmitoylation reduces amyloid burden and mitigates memory deficits in transgenic mouse models of Alzheimer’s disease

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2017-10-23

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/pnas.1708568114PMID 29078331PMCID PMC5692556
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease

  2017cited by this paper
• Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease

  2017cited by this paper
• Activity-Dependent Palmitoylation Controls SynDIG1 Stability, Localization, and Function

  2016cited by this paper
• Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer’s disease

  2016cited by this paper
• Functions of the Alzheimer’s Disease Protease BACE1 at the Synapse in the Central Nervous System

  2016cited by this paper
• Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibition Impairs Synaptic Plasticity via Seizure Protein 6.

  2016cited by this paper
• Significance of transcytosis in Alzheimer's disease: BACE1 takes the scenic route to axons

  2015cited by this paper
• Massive accumulation of luminal protease-deficient axonal lysosomes at Alzheimer’s disease amyloid plaques

  2015cited by this paper
• Behavioral abnormalities in APPSwe/PS1dE9 mouse model of AD-like pathology: comparative analysis across multiple behavioral domains.

  2015cited by this paper
• Chronic optogenetic activation augments aβ pathology in a mouse model of Alzheimer disease.

  2015cited by this paper
• Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models

  2014cited by this paper
• Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects

  2014cited by this paper
• Axonal BACE1 dynamics and targeting in hippocampal neurons: a role for Rab11 GTPase

  2014influential reference
• Molecular Mechanisms of Alzheimer’s Disease Protection by the A673T Allele of Amyloid Precursor Protein

  2014cited by this paper
• Palmitoylation-dependent regulation of glutamate receptors and their PDZ domain-containing partners.

  2013cited by this paper
• A function for EHD family proteins in unidirectional retrograde dendritic transport of BACE1 and Alzheimer's disease Aβ production.

  2013influential reference
• What does S‐palmitoylation do to membrane proteins?

  2013cited by this paper
• The Alzheimer’s β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques

  2013cited by this paper
• The precision of axon targeting of mouse olfactory sensory neurons requires the BACE1 protease

  2012cited by this paper
• A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline

  2012cited by this paper
• β-Site Amyloid Precursor Protein (APP)-cleaving Enzyme 1 (BACE1)-deficient Mice Exhibit a Close Homolog of L1 (CHL1) Loss-of-function Phenotype Involving Axon Guidance Defects*♦

  2012cited by this paper
• Neuronal β-amyloid generation is independent of lipid raft association of β-secretase BACE1: analysis with a palmitoylation-deficient mutant

  2012cited by this paper
• Depletion of GGA1 and GGA3 Mediates Postinjury Elevation of BACE1

  2012cited by this paper
• Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons

  2012influential reference
• Palmitoylation of A-Kinase Anchoring Protein 79/150 Regulates Dendritic Endosomal Targeting and Synaptic Plasticity Mechanisms

  2012cited by this paper
• Transgenic neuronal overexpression reveals that stringently regulated p23 expression is critical for coordinated movement in mice

  2011cited by this paper
• The Alzheimer's β-secretase enzyme BACE1 is required for accurate axon guidance of olfactory sensory neurons and normal glomerulus formation in the olfactory bulb

  2011cited by this paper
• Integrated behavioral z-scoring increases the sensitivity and reliability of behavioral phenotyping in mice: relevance to emotionality and sex.

  2011cited by this paper
• Site-specific analysis of protein S-acylation by resin-assisted capture[S]

  2011cited by this paper
• Neuronal activity regulates the regional vulnerability to amyloid-β deposition

  2011influential reference
• BACE1 Elevation is Involved in Amyloid Plaque Development in the Triple Transgenic Model of Alzheimer’s Disease: Differential Aβ Antibody Labeling of Early-Onset Axon Terminal Pathology

  2011cited by this paper
• Reduced Alzheimer's Disease β-Amyloid Deposition in Transgenic Mice Expressing S-Palmitoylation-Deficient APH1aL and Nicastrin

  2010cited by this paper
• Greasing their way: lipid modifications determine protein association with membrane rafts.

  2010cited by this paper
• Regulation of AMPA receptor extrasynaptic insertion by 4.1N, phosphorylation and palmitoylation

  2009cited by this paper
• A Recessive Mutation in the APP Gene with Dominant-Negative Effect on Amyloidogenesis

  2009cited by this paper
• Dual palmitoylation of NR2 subunits regulates NMDA receptor trafficking.

  2009cited by this paper
• S-Palmitoylation of γ-Secretase Subunits Nicastrin and APH-1*

  2009cited by this paper
• Alzheimer Disease Aβ Production in the Absence of S-Palmitoylation-dependent Targeting of BACE1 to Lipid Rafts*

  2009cited by this paper
• Amyloid Precursor Protein Trafficking, Processing, and Function*

  2008cited by this paper
• Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo.

  2008cited by this paper
• Palmitoylation and ubiquitination regulate exit of the Wnt signaling protein LRP6 from the endoplasmic reticulum

  2008cited by this paper
• Neural Palmitoyl-Proteomics Reveals Dynamic Synaptic Palmitoylation

  2008cited by this paper
• Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis.

  2007cited by this paper
• Palmitoylation: policing protein stability and traffic

  2007cited by this paper
• β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Levels Become Elevated in Neurons around Amyloid Plaques: Implications for Alzheimer's Disease Pathogenesis

  2007cited by this paper
• Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation

  2006influential reference
• Control of Peripheral Nerve Myelination by the ß-Secretase BACE1

  2006cited by this paper
• Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1

  2006cited by this paper
• Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo.

  2005cited by this paper
• BACE overexpression alters the subcellular processing of APP and inhibits Aβ deposition in vivo

  2005cited by this paper
• Differential regulation of AMPA receptor subunit trafficking by palmitoylation of two distinct sites.

  2005cited by this paper
• Spatial segregation of gamma-secretase and substrates in distinct membrane domains.

  2005cited by this paper
• Spatial Segregation of γ-Secretase and Substrates in Distinct Membrane Domains*

  2005cited by this paper
• Palmitoylation controls trafficking of GAD65 from Golgi membranes to axon-specific endosomes and a Rab5a-dependent pathway to presynaptic clusters

  2004cited by this paper
• Labeling and quantifying sites of protein palmitoylation.

  2004cited by this paper
• An evolutionarily conserved dileucine motif in Shal K+ channels mediates dendritic targeting

  2003cited by this paper
• Polarized Targeting of Peripheral Membrane Proteins in Neurons*

  2001cited by this paper
• Dual Palmitoylation of Psd-95 Mediates Its Vesiculotubular Sorting, Postsynaptic Targeting, and Ion Channel Clustering

  2000cited by this paper
• Stable association of presenilin derivatives and absence of presenilin interactions with APP.

  1998cited by this paper
• Alzheimer Amyloid Protein Precursor in the Rat Hippocampus: Transport and Processing through the Perforant Path

  1998influential reference
• Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease.

  1997cited by this paper
• Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo.

  1996cited by this paper
• Metabolism of the Swedish Amyloid Precursor Protein Variant in Neuro2a (N2a) Cells

  1996cited by this paper
• Distribution of an APP homolog, APLP2, in the mouse olfactory system: a potential role for APLP2 in axogenesis

  1995cited by this paper
• Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

  1995influential reference
• The Swedish mutation causes early-onset Alzheimer's disease by β-secretase cleavage within the secretory pathway

  1995cited by this paper
• Amyloid precursor-like protein 2 (APLP2) is modified by the addition of chondroitin sulfate glycosaminoglycan at a single site.

  1994cited by this paper
• Release of excess amyloid beta protein from a mutant amyloid beta protein precursor.

  1993cited by this paper
• Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production

  1992cited by this paper
• Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production.

  1992cited by this paper
• A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloid

  1992cited by this paper
• Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport.

  1990cited by this paper

• Sex-dependent rescue of memory and synaptic deficits in AD model mice by increasing PSD-95 palmitoylation.

  2026cites this paper
• Landscape of Protein Post-Translational Modifications in Age-Related Neurodegenerative Disorders: Implications in Protein Aggregation, Altered Cellular Processes, and Therapeutics.

  2026cites this paper
• Protein palmitoylation: an emerging regulator of inflammatory signaling and diseases

  2025cites this paper
• Deciphering the Structural Biology of GFAP: Connotations of Its Potency in Presaging the Diagnosis for Traumatic Brain Injury and AD

  2025cites this paper
• GluA2 palmitoylation by SELENOK modulates AMPAR assembly and synaptic plasticity in Alzheimer's disease

  2025cites this paper
• Palmitoylation: an emerging therapeutic target bridging physiology and disease

  2025cites this paper
• RhoA regulates membrane order and tension to control excitability of nociceptor neurons

  2025cites this paper
• Palmitoylation-related gene ZDHHC22 as a potential diagnostic and immunomodulatory target in Alzheimer’s disease: insights from machine learning analyses and WGCNA

  2025cites this paper
• Protein palmitoylation: biological functions, disease, and therapeutic targets

  2025cites this paper
• Recent advances in S-palmitoylation and its emerging roles in human diseases

  2025cites this paper
• Cleavage efficiency of the intramembrane protease γ‐secretase is reduced by the palmitoylation of a substrate's transmembrane domain

  2024cites this paper
• Reduction of DHHC5-mediated beclin 1 S-palmitoylation underlies autophagy decline in aging

  2024cites this paper
• Inhibition of zDHHC7-driven protein S-palmitoylation prevents cognitive deficits in an experimental model of Alzheimer’s disease

  2024cites this paper
• Altered Protein Palmitoylation as Disease Mechanism in Neurodegenerative Disorders

  2024cites this paper
• Role of palmitoylation on the neuronal glycine transporter GlyT2

  2024cites this paper
• A Comprehensive Review on Alzheimer’s Disease; Pathophysiology and Treatment

  2024cites this paper
• Cholesterol and Lipid Rafts in the Biogenesis of Amyloid-β Protein and Alzheimer's Disease.

  2024cites this paper
• The role of s-palmitoylation in neurological diseases: implication for zDHHC family

  2024cites this paper
• Control of mitochondria-associated endoplasmic reticulum membranes by protein S-palmitoylation：novel therapeutic targets for neurodegenerative diseases.

  2023cites this paper
• Membrane lipid nanodomains modulate HCN pacemaker channels in nociceptor DRG neurons

  2023cites this paper
• Amyloid Precursor Protein and Alzheimer’s Disease

  2023cites this paper
• DIRECT REGULATION OF THE VOLTAGE-SENSING DOMAIN OF HCN CHANNELS BY MEMBRANE LIPID COMPARTMENTALIZATION

  2023cites this paper
• Characterizing the transmembrane domains of ADAM10 and BACE1 and the impact of membrane composition.

  2023cites this paper
• Roles of protein post-translational modifications in glucose and lipid metabolism: mechanisms and perspectives

  2023cites this paper
• S‐palmitoylation regulates innate immune signaling pathways: molecular mechanisms and targeted therapies

  2023cites this paper
• Direct regulation of the voltage sensor of HCN channels by membrane lipid compartmentalization

  2023cites this paper
• Lost in traffic: consequences of altered palmitoylation in neurodegeneration

  2023cites this paper
• Mechanisms of amyloid-β34 generation indicate a pivotal role for BACE1 in amyloid homeostasis

  2023cites this paper
• Clinical relevance of biomarkers, new therapeutic approaches, and role of post-translational modifications in the pathogenesis of Alzheimer’s disease

  2022cites this paper
• Neuronal KCNQ2/3 channels are recruited to lipid raft microdomains by palmitoylation of BACE1

  2022cites this paper
• Cln5 represents a new type of cysteine-based S-depalmitoylase linked to neurodegeneration

  2022cites this paper
• Cattle Encephalon Glycoside and Ignotin Ameliorate Palmitoylation of PSD-95 and Enhance Expression of Synaptic Proteins in the Frontal Cortex of a APPswe/PS1dE9 Mouse Model of Alzheimer’s Disease

  2022cites this paper
• A TNF receptor 2 agonist ameliorates neuropathology and improves cognition in an Alzheimer’s disease mouse model

  2022cites this paper
• Altered pain sensitivity in 5×familial Alzheimer disease mice is associated with dendritic spine loss in anterior cingulate cortex pyramidal neurons

  2022cites this paper
• Protein acylation: mechanisms, biological functions and therapeutic targets

  2022cites this paper
• Roles of palmitoylation in structural long-term synaptic plasticity

  2021cites this paper
• How palmitoylation affects trafficking and signaling of membrane receptors

  2021cites this paper
• Changes of blood-brain-barrier function and transfer of amyloid beta in rats with collagen-induced arthritis

  2021cites this paper
• Transgenic Mice

  2021cites this paper
• An Overview of β-Amyloid Cleaving Enzyme 1 (Bace1) in Alzheimer's Disease Therapy Elucidating its Exosite-Binding Antibody and Allosteric Inhibitor.

  2021cites this paper
• PSD-95 protects synapses from β-amyloid

  2021cites this paper
• The C99 domain of the amyloid precursor protein resides in the disordered membrane phase

  2021cites this paper
• Changes of blood-brain-barrier function and transfer of amyloid beta in rats with collagen-induced arthritis

  2021cites this paper
• Post-Translational Modifications of BACE1 in Alzheimer's Disease

  2021cites this paper
• FATTY ACIDS AS CELL SIGNALS IN INGESTIVE BEHAVIORS.

  2020cites this paper
• Polyunsaturated Fatty Acid Composition of Cerebrospinal Fluid Fractions Shows Their Contribution to Cognitive Resilience of a Pre-symptomatic Alzheimer’s Disease Cohort

  2020cites this paper
• Drug design targeting active posttranslational modification protein isoforms

  2020cites this paper
• Gga3 deletion and a GGA3 rare variant associated with late onset Alzheimer’s disease trigger BACE1 accumulation in axonal swellings

  2020cites this paper
• Protein palmitoylation and its pathophysiological relevance

  2020cites this paper
• Recruitment of Neuronal KCNQ2/3 Channels to Membrane Microdomains by Palmitoylation of Alzheimer’s Disease-Related Protein BACE1

  2020cites this paper
• The role of GLP-1/GIP receptor agonists in Alzheimer's disease.

  2020cites this paper
• GPS-Palm: a deep learning-based graphic presentation system for the prediction of S-palmitoylation sites in proteins

  2020cites this paper
• APP-Mediated Signaling Prevents Memory Decline in Alzheimer's Disease Mouse Model.

  2019cites this paper
• Transgenic Mice

  2019cites this paper
• Understanding the role of AKAP150 palmitoylation in synaptic plasticity

  2019cites this paper
• Therapeutic targeting of protein S-acylation for the treatment of disease.

  2019cites this paper
• Role of Post‐translational Modifications in Alzheimer's Disease

  2019cites this paper
• Alzheimer's disease: The derailed repair hypothesis.

  2019cites this paper
• Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer’s disease model

  2019cites this paper
• Trafficking and proteolytic processing of amyloid precursor protein and secretases in Alzheimer's disease development: An up-to-date review.

  2019cites this paper
• pHluorin-BACE1-mCherry Acts as a Reporter for the Intracellular Distribution of Active BACE1 In Vitro and In Vivo

  2019cites this paper
• Palmitic Acid-Induced NAD+ Depletion is Associated with the Reduced Function of SIRT1 and Increased Expression of BACE1 in Hippocampal Neurons

  2019cites this paper
• Reduction of the expression of the late-onset Alzheimer's disease (AD) risk-factor BIN1 does not affect amyloid pathology in an AD mouse model

  2019influential citation
• Polarized trafficking: the palmitoylation cycle distributes cytoplasmic proteins to distinct neuronal compartments.

  2018cites this paper
• Insights Into Protein S-Palmitoylation in Synaptic Plasticity and Neurological Disorders: Potential and Limitations of Methods for Detection and Analysis

  2018cites this paper
• Cholesterol and ApoE in Alzheimer’s disease

  2018cites this paper
• Consequences of Pharmacological BACE Inhibition on Synaptic Structure and Function.

  2018cites this paper
• Practical considerations for choosing a mouse model of Alzheimer’s disease

  2017cites this paper
• RhoA activation promotes ordered membrane domain coalescence and suppresses neuronal excitability

  year unknowncites this paper
• Exploring flavonoids as multi-target therapeutic agents in Alzheimer’s disease: Insights from Network Pharmacology, Molecular Docking, and Dynamics

  year unknowncites this paper